Pages that link to "Item:Q4649069"
From MaRDI portal
The following pages link to Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials (Q4649069):
Displaying 8 items.
- Two-stage design for phase II oncology trials with relaxed futility stopping (Q1747566) (← links)
- Randomized phase II cancer clinical trials (Q2852232) (← links)
- Optimal adaptive two-stage designs for phase II cancer clinical trials (Q2858002) (← links)
- Decision-Theoretic Designs for Pre-Phase II Screening Trials in Oncology (Q3078865) (← links)
- MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION (Q4512728) (← links)
- Stopping for efficacy in single-arm phase II clinical trials (Q5093024) (← links)
- Making Efficient Use of Patients in Designing Phase III Trials Investigating Simultaneously a Set of Targeted Therapies with Different Targets (Q5122882) (← links)
- Exact confidence limits after a group sequential single arm binary trial (Q6627784) (← links)